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Cross-Linking of Elafin/SKALP to 
Elastic Fibers in Photodamaged Skin: 
Too Much of a Good Thing?
Joost Schalkwijk1
Muto et al. report that UVA light induces the expression of elafin, a potent 
elastase inhibitor, in skin fibroblasts. Elafin binds to elastic fibers by transglu-
taminase-mediated cross-linking and protects against proteolytic breakdown. 
Decreased degradation could contribute to accumulation of elastotic material 
in photodamaged skin. Elastase and its locally produced inhibitors play a role in 
actinic elastosis.
Journal of Investigative Dermatology (2007) 127, 1286–1287. doi:10.1038/sj.jid.5700691
The fibrillary basophilic material 
present in the upper dermis of photo-
damaged skin is largely composed of 
elastic material. It is unclear to what 
extent this accumulation is caused by 
increased synthesis of elastin or by 
breakdown of existing and nascent 
elastic fibers, or by a relative decrease 
of collagen (Lewis et al., 2004; 
Sellheyer, 2003).
The paper by Muto et al. (2007, this 
issue) contains two interesting new 
findings. First, it shows that the serine 
protease inhibitor elafin (Wiedow et 
al., 1990), otherwise known as skin-
derived antileukoproteinase (SKALP) 
(Molhuizen et al., 1993), can be 
expressed by mesenchymal cells. This is 
a surprising finding, as it was assumed 
that elafin expression was strictly lim-
ited to epithelial cells (Pfundt et al., 
1996). The authors confirm previous 
findings that resting skin fibroblasts in 
vivo and in vitro are negative for ela-
fin, but they show that UVA irradiation 
(and not UVB) induces elafin expres-
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sion in these cells. Second, it is shown 
that elafin binds to elastic fibers in vivo 
and in vitro, thereby protecting against 
elastase-mediated breakdown. Elafin 
is a member of the trappin gene family 
(Schalkwijk et al., 1999). The proteins 
encoded by the trappin family are char-
acterized by a proteinase-inhibiting 
whey acidic protein (WAP) domain and 
a domain that contains the consensus 
GQDPVK hexapeptide motifs that are 
excellent substrates for transglutamin-
ases (Molhuizen et al., 1993). Muto et 
al. (2007) show that, in vitro, elafin can 
be cross-linked to elastic fibers, while 
retaining its proteinase-inhibiting activ-
ity. Immunohistochemical analysis of 
skin biopsies from photodamaged skin 
showed strong elafin staining associ-
ated with the elastotic material. The 
accumulation of elastase inhibitors on 
elastic fibers is not unprecedented, 
as the association of another WAP 
domain protein, secretory leukocyte 
protease inhibitor (SLPI), has been 
documented in connective tissue of 
the lung (Kramps et al., 1989) and skin 
(Wingens et al., 1998).
On the basis of their findings, Muto et 
al. (2007) speculate that elafin binding 
to elastic fibers is a protective response 
against undesirable degradative action 
of elastolytic enzymes such as neutro-
phil elastase derived from the infiltrating 
cells after UV irradiation (Hawk et al., 
1988). The authors argue that the accu-
mulation of elastotic material in photo-
damaged skin is caused by decreased 
degradation of elastic fibers rather than 
by overproduction of elastic fibers. The 
findings in this paper are novel and 
exciting. I think, however, that the data 
are open to other interpretations than 
those offered by the authors. It is indeed 
very likely that elafin expression by 
fibroblasts after UVA exposure is a pro-
tective mechanism against unwanted 
breakdown of extracellular matrix mol-
ecules. I also agree with the authors that 
the accumulation of elastotic material in 
photodamaged skin could be the conse-
quence of a protective mechanism gone 
awry. Normal turnover of collagens 
and elastin is limited, and regenera-
tion of fully matured elastic fibers after 
skin injury happens very slowly, if at all. 
Teleologically speaking, our skin has 
ample reason to protect its elastic fibers, 
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and secretion of an elastase inhibitor 
following an insult (excessive UV light) 
makes sense. Chronic exposure to UV 
light would cause sustained production 
of elafin, and the action of transgluta-
minases will result in an irreversible 
covalent binding with elastic fibers.
Although this would position the 
protease inhibitor in exactly the right 
place to do its job, it also comes with 
a cost: modification of glutamines and 
lysines in the elastic fiber constituents. 
Accumulation of these modifications 
could in the end severely compromise 
the biochemical and cell-biological 
properties of these elastic fibers, includ-
ing resistance to breakdown and nor-
mal turnover, propensity to aggregate, 
and activation of fibroblasts to increase 
tropoelastin synthesis. The assertion 
by Muto et al. (2007) that fiber-associ-
ated elafin protects against breakdown 
does not, in itself, explain why there is 
a strong increase of elastic fiber material 
in photodamaged skin. There are, how-
ever, some lessons to be learned from a 
mouse model. Chronic UV irradiation 
of hairless mice is a model for actinic 
elastosis (Starcher and Conrad, 1995). 
It was shown, however, that mice that 
lack neutrophil elastase do not accumu-
late elastic fibers; this suggests a role for 
elastase not only in breakdown but also 
in increased production of elastic fibers. 
There is no mouse ortholog for the 
human elafin gene, but mice do have 
SLPI, which probably has the same func-
tion. Taken together, these observations 
suggest that elastase activity promotes 
elastin synthesis, possibly in an indi-
rect way following the release of break-
down products of the elastic fibers. This 
process could be controlled to some 
extent by the local induction of elastase 
inhibitors such as elafin (Muto et al., 
2007) and SLPI (Wingens et al., 1998). 
When these safeguards fail, excess 
elastase activity cannot be controlled. 
Speculatively, elastic fibers altered by 
transglutaminase-mediated cross-linking 
and increased elastin production will 
in the end lead to the elastotic material 
seen in photodamaged skin.
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Opioids and the Skin: “Itchy” 
Perspectives beyond Analgesia and 
Abuse
Martin Schmelz1 and Ralf Paus2
Opioids are intimately linked to central pain inhibition and their abuse poten-
tial. Thus, peripheral opioid receptors in the skin have been studied initially with 
a focus on their peripheral analgesic properties. Recent results, however, clearly 
indicate that opioids play a specific role in skin homeostasis by modulating kera-
tinocyte differentiation, wound healing, and inflammatory responses.
Journal of Investigative Dermatology (2007) 127, 1287–1289. doi:10.1038/sj.jid.5700634
Traditionally, opioid research is 
focused on the powerful inhibition of 
central pain pathways by opioid recep-
tor ligands, an effect that has been clin-
ically exploited for centuries. Like the 
habitual abuse of exogenous opioids 
— a matter of much scientific scrutiny 
and heated political debate — analge-
sic therapy with exogenous opioids has 
long been known to be associated with 
intense generalized pruritus (Twycross 
et al., 2003; Gutstein and Akil, 2001). 
And yet, this ancient lead toward the 
peripheral activities of opioids has 
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